MerckInc Overview
MerckInc Target Price
Analysts' 12-month price predictions for MRK.
Share Price
$128.8
Average Target Price
$140.67
9.2% upside
9.2% upside3 analysts in the last 4 months
High: $145 | Low: $135
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-03-27 | Truist Financial | $142 | 10.2% upside |  |
| 2024-03-27 | JefferiesAkash Tewari | $145 | 12.6% upside | |
| 2024-03-27 | Wells FargoMohit Bansal | $135 | 4.8% upside | |
| 2023-11-22 | Loop Capital MarketsEvan David Seigerman | $132 | 2.5% upside | |
| 2023-04-12 | OppenheimerJay Olson | $294 | 128.3% upside | |
| 2023-02-03 | Morgan Stanley | $99 |  23.1% downside | |
| 2023-02-03 | Wells Fargo | $120 | 6.8% downside | |
| 2023-01-03 | Wells Fargo | $125 | 3% downside | |
| 2022-12-19 | Cantor Fitzgerald | $135 | 4.8% upside | |
| 2022-11-18 | Credit Suisse | $120 | 6.8% downside | |
| 2022-09-30 | Leerink Partners | $110 | 14.6% downside | |
| 2022-09-12 | Leerink Partners | $109 | 15.4% downside | |
| 2022-07-29 | Morgan Stanley | $92 | 28.6% downside | |
| 2022-07-29 | Barclays | $101 | 21.6% downside | |
| 2022-07-29 | Leerink Partners | $105 | 18.5% downside | |
| 2022-07-18 | UBS | $98 | 23.9% downside | |
| 2022-07-13 | Atlantic Equities | $110 | 14.6% downside | |
| 2022-07-08 | Morgan Stanley | $88 | 31.7% downside | |
| 2022-04-29 | Morgan Stanley | $87 | 32.5% downside | |
| 2022-04-29 | Leerink Partners | $102 | 20.8% downside | |
| 2022-04-21 | Leerink Partners | $97 | 24.7% downside | |
| 2022-04-16 | BarclaysCarter Gould | $97 | 24.7% downside | |
| 2022-04-11 | Morgan StanleyTerence Flynn | $80 | 37.9% downside | |
| 2022-04-10 | BMO CapitalEvan David Seigerman | $87 | 32.5% downside | |
| 2021-12-17 | Goldman SachsChris Shibutani | $93 | 27.8% downside | |
| 2021-12-13 | UBSColin Bristow | $76 | 41% downside | |
| 2021-11-29 | CitigroupAndrew Baum | $85 | 34% downside | |
| 2021-11-01 | BarclaysCarter Gould | $94 | 27% downside | |
| 2021-11-01 | Argus ResearchDavid Toung | $110 | 14.6% downside | |
| 2021-10-29 | Wolfe ResearchTim Anderson | $94 | 27% downside | |
| 2021-10-29 | Bank of America SecuritiesGeoff Meacham | $86 | 33.2% downside | |
| 2021-07-29 | RBC CapitalDaniel Busby | $80 | 37.9% downside | |